West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$256.64 USD
-1.71 (-0.66%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $256.67 +0.03 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, West Pharmaceutical Services, Inc. has a market cap of $18.58B, which represents its share price of $258.35 multiplied by its outstanding shares number of 71.91M. As a large-cap company, WST's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
WST 256.64 -1.71(-0.66%)
Will WST be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WST
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care
CAH Strengthens Distribution With New Consumer Health Logistics Hub
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
GEHC Expands Women's Health Portfolio With AI-Enabled Voluson
ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5
GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio
Other News for WST
WST rises 0.32% on September 16, leaving the technical picture intact
Optimistic Long-Term Growth Outlook for Wingstop Amid Strategic Initiatives and Expansion Plans
Is WST consolidating before a move? NR7 shows up after gaining 1.59%
Rothschild & Co Initiates Coverage on WST with a 'Buy' Rating | WST Stock News
West Pharmaceutical Services (WST) Has a New Rating from Redburn Atlantic